Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection

被引:57
作者
Wieland, Andreas [1 ,2 ]
Shashidharamurthy, Rangaiah [3 ]
Kamphorst, Alice O. [1 ,2 ]
Han, Jin-Hwan [1 ,2 ]
Aubert, Rachael D. [1 ,2 ]
Choudhury, Biswa P. [5 ]
Stowell, Sean R. [3 ]
Lee, Junghwa [1 ,2 ]
Punkosdy, George A. [1 ,2 ]
Shlomchik, Mark J. [4 ]
Selvaraj, Periasamy [3 ]
Ahmed, Rafi [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IMMUNE-COMPLEX DISEASE; T-CELL RESPONSES; IN-VIVO; B-CELLS; ANTITUMOR ACTIVITIES; DENDRITIC CELLS; BREAST-CANCER; STEM-CELLS; THERAPY;
D O I
10.1016/j.immuni.2015.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell dysfunction is well documented during chronic viral infections but little is known about functional abnormalities in humoral immunity. Here we report that mice persistently infected with lymphocytic choriomeningitis virus (LCMV) exhibit a severe defect in Fc gamma-receptor (Fc gamma R)-mediated antibody effector functions. Using transgenic mice expressing human CD20, we found that chronic LCMV infection impaired the depletion of B cells with rituximab, an anti-CD20 antibody widely used for the treatment of B cell lymphomas. In addition, Fc gamma R-dependent activation of dendritic cells by agonistic anti-CD40 antibody was compromised in chronically infected mice. These defects were due to viral antigen-anti-body complexes and not the chronic infection per se, because Fc gamma R-mediated effector functions were normal in persistently infected mice that lacked LCMV-specific antibodies. Our findings have implications for the therapeutic use of antibodies and suggest that high levels of pre-existing immune complexes could limit the effectiveness of antibody therapy in humans.
引用
收藏
页码:367 / 378
页数:12
相关论文
共 54 条
[11]   B cells move to centre stage: novel opportunities for autoimmune disease treatment [J].
Browning, Jeffrey L. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (07) :564-576
[12]  
BUCHMEIER MJ, 1978, J IMMUNOL, V120, P1297
[13]   Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma [J].
Chao, Mark P. ;
Alizadeh, Ash A. ;
Tang, Chad ;
Myklebust, June H. ;
Varghese, Bindu ;
Gill, Saar ;
Jan, Max ;
Cha, Adriel C. ;
Chan, Charles K. ;
Tan, Brent T. ;
Park, Christopher Y. ;
Zhao, Feifei ;
Kohrt, Holbrook E. ;
Malumbres, Raquel ;
Briones, Javier ;
Gascoyne, Randy D. ;
Lossos, Izidore S. ;
Levy, Ronald ;
Weissman, Irving L. ;
Majeti, Ravindra .
CELL, 2010, 142 (05) :699-713
[14]   Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma [J].
Cheson, Bruce D. ;
Leonard, John P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) :613-626
[15]   Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo [J].
DiLillo, David J. ;
Tan, Gene S. ;
Palese, Peter ;
Ravetch, Jeffrey V. .
NATURE MEDICINE, 2014, 20 (02) :143-151
[16]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[17]   Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy [J].
Gong, Q ;
Ou, QL ;
Ye, SM ;
Lee, WP ;
Cornelius, J ;
Diehl, L ;
Lin, WY ;
Hu, ZL ;
Lu, YM ;
Chen, YM ;
Wu, Y ;
Meng, YG ;
Gribling, P ;
Lin, ZH ;
Nguyen, K ;
Tran, T ;
Zhang, YF ;
Rosen, H ;
Martin, F ;
Chan, AC .
JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :817-826
[18]   Thy-1: More than a mouse pan-T cell marker [J].
Haeryfar, SMM ;
Hoskin, DW .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3581-3588
[19]   Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice [J].
Halper-Stromberg, Ariel ;
Lu, Ching-Lan ;
Klein, Florian ;
Horwitz, Joshua A. ;
Bournazos, Stylianos ;
Nogueira, Lilian ;
Eisenreich, Thomas R. ;
Liu, Cassie ;
Gazumyan, Anna ;
Schaefer, Uwe ;
Furze, Rebecca C. ;
Seaman, Michael S. ;
Prinjha, Rab ;
Tarakhovsky, Alexander ;
Ravetch, Jeffrey V. ;
Nussenzweig, Michel C. .
CELL, 2014, 158 (05) :989-999
[20]   Fc receptor but not complement binding is important in antibody protection against HIV [J].
Hessell, Ann J. ;
Hangartner, Lars ;
Hunter, Meredith ;
Havenith, Carin E. G. ;
Beurskens, Frank J. ;
Bakker, Joost M. ;
Lanigan, Caroline M. S. ;
Landucci, Gary ;
Forthal, Donald N. ;
Parren, Paul W. H. I. ;
Marx, Preston A. ;
Burton, Dennis R. .
NATURE, 2007, 449 (7158) :101-U75